Clinical trial participants in Novavax Covid trial in the dark on whether to get approved jabs

Sally Whyte
By Sally Whyte
Updated June 7 2021 - 8:16am, first published 2:00am
Blood samples to be sent for immunogenicity testing at the Paratus clinical testing site in Canberra. Picture: Sitthixay Ditthavong

Participants in a clinical trial for a vaccine against COVID-19 that is yet to be approved in Australia could have their vaccine recorded on the Australian Immunisation Register, but some say they have been left in the dark about whether to line up for a new jab as part of the government's vaccine rollout.

Advertisement

Ad

Advertisement

Ad

Advertisement

Ad
Sally Whyte

Sally Whyte

Federal Politics Reporter

I report on a range of issues in federal politics and the public service, with a real passion for how decisions made in Canberra affect the lives of Australians.

Get the latest Canberra news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.